On the public citation graph

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial

0 signed · 24 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ejhf.1858openalex-snapshot
Epidemiology of Heart Failure
inferredcites →https://doi.org/10.1007/s11886-021-01588-yopenalex-snapshot
Improving Quality of Life in Heart Failure
inferredcites →https://doi.org/10.1016/j.clinbiochem.2018.07.002openalex-snapshot
Diagnostic concordance between NT-proBNP and BNP for suspected heart failure
inferredcites →https://doi.org/10.1016/j.jacc.2013.05.035openalex-snapshot
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure
inferredcites →https://doi.org/10.1016/j.jep.2020.112573openalex-snapshot
Qishen Granule alleviates endoplasmic reticulum stress-induced myocardial apoptosis through IRE-1-CRYAB pathway in myocardial ischemia
inferredcites →https://doi.org/10.1016/j.jep.2021.114841openalex-snapshot
Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats
inferredcites →https://doi.org/10.1016/s2214-109x(17)30196-1openalex-snapshot
Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study
inferredcites →https://doi.org/10.1080/00365513.2019.1622034openalex-snapshot
NT-proBNP to exclude heart failure in primary care – a pragmatic, cluster-randomized study
inferredcites →https://doi.org/10.1155/2020/1868974openalex-snapshot
The Protective Effect of Qishen Granule on Heart Failure after Myocardial Infarction through Regulation of Calcium Homeostasis
inferredcites →https://doi.org/10.1161/cir.0000000000001063openalex-snapshot
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
inferredcites →https://doi.org/10.1161/circulationaha.120.050850openalex-snapshot
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries
inferredcites →https://doi.org/10.1186/s13063-017-2193-zopenalex-snapshot
Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial
inferredcites →https://doi.org/10.3390/ijerph13080770openalex-snapshot
Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction: A Population-Based Study in Northeast China

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4752183openalex-extracted
Yixinjiedu Formula Inhibits Ferroptosis by Regulating PINK1/Parkin-Mediated Mitophagy to Attenuate Pressure Overload-Induced Cardiac Dysfunction
inferred← citeshttps://doi.org/10.2139/ssrn.4824989openalex-extracted
Traditional Chinese Medicine for Cardiovascular Disease: Efficacy and Safety
inferred← citeshttps://doi.org/10.1007/s11010-026-05540-yopenalex-snapshot
Targeting YAP: mechanistic breakthroughs and therapeutic prospects in reversing organ fibrosis
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.157020openalex-snapshot
Traditional Chinese medicine protects against doxorubicin cardiotoxicity via epigenetic modification and beyond
inferred← citeshttps://doi.org/10.1016/s1875-5364(26)61104-1openalex-snapshot
Mitochondrial dysfunction: a new target for traditional Chinese medicine in the treatment of chronic heart failure
inferred← citeshttps://doi.org/10.1186/s12906-025-05029-zopenalex-snapshot
Efficacy and safety of Qishen granule for treating heart failure with preserved ejection fraction: a study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1186/s13020-026-01461-6openalex-snapshot
Qishen Granules attenuate adverse ventricular remodeling in chronic heart failure by promoting Legumain/Arg1/Rac1-mediated efferocytosis of resident cardiac macrophages
inferred← citeshttps://doi.org/10.3389/fcvm.2024.1419169openalex-snapshot
Traditional Chinese medicine for cardiovascular disease: efficacy and safety
inferred← citeshttps://doi.org/10.3389/fcvm.2026.1897966openalex-snapshot
Long-term efficacy and impact on rehospitalization of Qishen granules in patients with hypertension and heart failure with reduced ejection fraction: a multicenter, randomized, double-blind, placebo-controlled trial protocol
inferred← citeshttps://doi.org/10.3389/fphar.2024.1434654openalex-snapshot
Role of macrophage polarization in heart failure and traditional Chinese medicine treatment
inferred← citeshttps://doi.org/10.3389/fphar.2025.1679085openalex-snapshot
The crosstalk between mitochondrial dysfunction and fatty acid metabolism in heart failure: mechanisms and therapeutic strategies
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.